Donor APCs are required for maximal GVHD but not for GVL

Nature Medicine

Volumn 10, Issue 9, 2004, Pages 987-992

  Matte, Catherine C ^a   Liu, Jinli ^a   Cormier, James ^b   Anderson, Britt E ^a   Athanasiadis, Ioanna ^a   Jain, Dhanpat ^a   McNiff, Jennifer ^a   Shlomchik, Warren D ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MINOR HISTOCOMPATIBILITY ANTIGEN;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL FUNCTION; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CROSS REACTION; DISEASE SEVERITY; DONOR; EXPERIMENTAL MODEL; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; GRAFT VERSUS LEUKEMIA EFFECT; HISTOPATHOLOGY; IMMUNE RESPONSE; INFECTION SENSITIVITY; MALE; MORTALITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RECIPIENT; T LYMPHOCYTE; TARGET CELL; WILD TYPE;

ANIMALS; ANTIGEN-PRESENTING CELLS; BONE MARROW TRANSPLANTATION; CD8-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GRAFT VS HOST DISEASE; GRAFT VS LEUKEMIA EFFECT; HISTOLOGICAL TECHNIQUES; LEUKEMIA, MYELOID, CHRONIC-PHASE; MICE; MICE, INBRED C3H; SPLEEN;

ANIMALIA;

EID: 4644269742     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1089     Document Type: Article

References (29)

1. Goker, H., Haznedaroglu, I.C. & Chao, N.J. Acute graft-vs-host disease: Pathobiology and management. Exp. Hematol. 29, 259-277 (2001).
2. Shlomchik, W.D. et al. Prevention of graft versus host disease by inactivation of host antigen-presenting cells. Science 285, 412-415 (1999).
3. Bland, P.W. & Whiting, C.V. Induction of MHC class II gene products in rat intestinal epithelium during graft-versus-host disease and effects on the immune function of the epithelium. Immunology 75, 356-371 (1992).
4. Matte, C.C. et al. Graft-versus-leukemia in a retrovirally induced murine CML model: mechanisms of T-cell killing. Blood 103, 4353-4361 (2004).
5. Pear, W.S. et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr/abl-transduced bone marrow. Blood 92, 3780-3792 (1998).
6. Daley, G.Q., Van Etten, R.A. & Baltimore, D. Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome. Science 247, 824-830 (1990).
7. Kaech, S.M. & Ahmed, R. Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naive cells. Nat. Immunol. 2, 415-422 (2001).
8. van Stipdonk, M.J., Lemmens, E.E. & Schoenberger, S.P. Naive CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation. Nat. Immunol. 2, 423-429 (2001).
9. Mintern, J.D. et al. Cutting edge: precursor frequency affects the helper dependence of cytotoxic T cells. J. Immunol. 168, 977-980 (2002).
10. Iezzi, G., Karjalainen, K. & Lanzavecchia, A. The duration of antigenic stimulation determines the fate of naive and effector T cells. Immunity 8, 89-95 (1998).
11. Croft, M., Bradley, L.M. & Swain, S.L. Naive versus memory CD4 T cell response to antigen. Memory cells are less dependent on accessory cell costimulation and can respond to many antigen-presenting cell types including resting B cells. J. Immunol. 152, 2675-2685 (1994).
12. Kedl, R.M. & Mescher, M.F. Qualitative differences between naive and memory T cells make a major contribution to the more rapid and efficient memory CD8+ T cell response. J. Immunol. 161, 674-683 (1998).
13. Zimmermann, C., Prevost-Blondel, A., Blaser, C. & Pircher, H. Kinetics of the response of naive and memory CD8 T cells to antigen: similarities and differences. Eur. J. Immunol. 29, 284-290 (1999).
14. Cho, B.K., Wang, C., Sugawa, S., Eisen, H.N. & Chen, J. Functional differences between memory and naive CD8 T cells. Proc. Natl. Acad. Sci. USA 96, 2976-2981 (1999).
15. London, C. A., Lodge, M.P. & Abbas, A.K. Functional responses and costimulator dependence of memory CD4+ T cells. J. Immunol. 164, 265-72 (2000).
16. Sprent, J. T memory cells: quality not quantity. Curr. Biol. 12, R174-R176 (2002).
17. Le Bon, A. et al. Cross-priming of CD8(+) T cells stimulated by virus-induced type I interferon. Nat. Immunol. 4, 1009-1015 (2003).
18. Singh-Jasuja, H. et al. The heat shock protein gp96 induces maturation of dendritic cells and down-regulation of its receptor. Eur. J. Immunol. 30, 2211-2215 (2000).
19. Hu, H.M. et al. CD28, TNF receptor, and IL-12 are critical for CD4-independent cross-priming of therapeutic antitumor CD8+ T cells. J. Immunol. 169, 4897-4904 (2002).
20. Hoffmann, T.K., Meidenbauer, N., Muller-Berghaus, J., Storkus, W.J. & Whiteside, T.L. Proinflammatory cytokines and CD40 ligand enhance cross-presentation and cross-priming capability of human dendritic cells internalizing apoptotic cancer cells. J. Immunother. 24, 162-171 (2001).
21. Kopp, E. & Medzhitov, R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 15, 396-401 (2003).
22. Horowitz, M.M. et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 75, 555-562 (1990).
23. Kolb, H.J. et al. Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia. Blood 86, 2041-2050 (1995).
24. Choudhury, A. et al. Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia. Blood 89, 1133-1142 (1997).
25. Chakrabarti, S. et al. High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. Blood 99, 4357-4363 (2002).
26. Cragg, L. et al. A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease. Biol. Blood Marrow Transplant. 5, 441-447 (2000).
27. Bix, M. et al. Rejection of class I MHC-deficient haemopoietic cells by irradiated MHC-matched mice. Nature 349, 329-331 (1991).
28. Anderson, B.E. et al. Memory CD4+ T cells do not induce graft-versus-host disease. J. Clin. Invest. 112, 101-108 (2003).
29. Pear, W.S., Nolan, G.P., Scott, M.L. & Baltimore, D. Production of high-liter helper-free retroviruses by transient transfection. Proc. Natl. Acad. Sci. USA 90, 8392-8396 (1993).